STRATA Skin Sciences, Inc. (SSKN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

STRATA Skin Sciences, Inc. (SSKN) is down 99.6% since the beginning of the year. At $0 per share, SSKN is trading 99.9% below its 52-week high of $4. Investors who bought $1,000 worth of SSKN shares 5 years ago would now be looking at an investment worth $0.

STRATA Skin Sciences, Inc. (SSKN) has returned -99.56% so far this year and -99.72% over the past 12 months. Over the last ten years, SSKN has returned -58.23% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.

Based on dividend-adjusted daily data since Oct 28, 2005, SSKN's average daily return is +0.17%, while the average monthly return is -2.44%.

Historically, 36% of months were positive and 64% were negative. The best month was Sep 2011 with a return of +101.4%, while the worst month was Jul 2026 at -94.5%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.

On a daily basis, SSKN closed higher 43% of trading days. The best single day was Jul 24, 2026 with a return of +1,150.0%, while the worst single day was Jul 10, 2026 at -99.6%.

STRATA Skin Sciences, Inc. has an annualized alpha of 42.85%, beta of 0.62, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 28, 2005.

• This stock participated in 210.44% of S&P 500 Index downside but only -35.36% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.62 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SSKN ranks 50 for risk / return — above 50% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the STRATA Skin Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the STRATA Skin Sciences, Inc. was 100.00%, occurring on Jul 21, 2026. The portfolio has not yet recovered.

The current STRATA Skin Sciences, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of STRATA Skin Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how STRATA Skin Sciences, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.